ClinConnect ClinConnect Logo
Search / Trial NCT07152886

The Effects of Clostridium Butyricum on Adverse Events During Adjuvant Chemotherapy for Colorectal Cancer

Launched by THE AFFILIATED HOSPITAL OF QINGDAO UNIVERSITY ·

Trial Information

Current as of September 29, 2025

Not yet recruiting

Keywords

Colorectal Cancer Adjuvant Chemotherapy Clostridium Butyricum

ClinConnect Summary

This clinical trial is studying whether a helpful type of bacteria called Clostridium butyricum can reduce side effects in people receiving extra chemotherapy treatment after surgery for colorectal cancer, which is cancer in the colon or rectum. Chemotherapy can sometimes cause uncomfortable or harmful effects, and this study wants to see if taking this bacteria as a supplement can make treatment easier and safer.

The trial is open to adults of all genders who have colorectal cancer and are starting additional chemotherapy after surgery. While the study isn’t recruiting yet, eligible participants will be asked to take Clostridium butyricum during their chemotherapy and will be closely monitored for any side effects. This study is important because it may help improve the quality of life for people undergoing cancer treatment by reducing unwanted symptoms.

Gender

ALL

Eligibility criteria

About The Affiliated Hospital Of Qingdao University

The Affiliated Hospital of Qingdao University is a leading medical institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital leverages its extensive expertise in various medical disciplines to enhance patient care and contribute to the global medical community. With a strong focus on translational medicine, the Affiliated Hospital collaborates with academic and industry partners to facilitate the development of novel therapies and medical interventions, ensuring adherence to the highest ethical standards and regulatory guidelines. Through its commitment to excellence in research and patient outcomes, the hospital aims to drive significant advancements in medical science and improve the quality of life for patients.

Locations

Patients applied

0 patients applied

Trial Officials

Yanbing Zhou

Principal Investigator

The Affiliated Hospital of Qingdao University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported